KDM5B
protein-codinglysine demethylase 5B, the group of AT-rich interaction domain containing|PHD finger proteins|Lysine demethylases
Gene summary
This gene encodes a lysine-specific histone demethylase that belongs to the jumonji/ARID domain-containing family of histone demethylases. The encoded protein is capable of demethylating tri-, di- and monomethylated lysine 4 of histone H3. This protein plays a role in the transcriptional repression or certain tumor suppressor genes and is upregulated in certain cancer cells. This protein may also play a role in genome stability and DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
- JARID1B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~84.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019502
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0020850
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0007661
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0020850
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0001071
Submitter: ClinGen
*KDM5B* was first reported in relation to autosomal recessive intellectual disability in 2018 (Faundes, et al., PMID: 29276005). At least 9 unique variants (e.g. missense, nonsense, frameshift, splice site, large deletion, etc.) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, and experimental evidence. Variants in this gene have been reported in at least 5 probands in 3 publications (PMIDs: 29276005, 34573379, 30409806). Nine variants (missense, nonsense, frameshift, splice site, large deletion) that have been reported in 5 probands in 3 publications (PMIDs: 29276005, 34573379, 30409806) are included in this curation. Please note that due to limitations of the scoring interface, a proband who was compound heterozygous for a splice variant and a large deletion was not able to be formally entered and scored at 2 points (PMID:30409806). This gene-disease association is also supported by animal models, in vitro functional assays, and biochemical function studies (PMIDs: 30409806, 22020125). Of note, this gene has also been implicated in autosomal dominant intellectual disability, autism, and development disorder. These will be assessed separately. Although this curation reached Definitive, the classification has been modified to Moderate due to the small number of probands reported in the literature. More evidence is needed to establish this relationship definitively. In summary, there is moderate evidence to support this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 3/1/2022 (SOP Version 8).
Inheritance Pattern: SD
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0020850
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision making, and avoidance of unnecessary testing
Comments: Heterozygous variants appear to be able to cause an incompletely penetrant phenotype
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KDM5B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006618.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 56 | 5 | 63 | ||
| missense | 1 | 9 | 311 | 16 | 1 | 338 |
| nonsense | 13 | 34 | 9 | 56 | ||
| start loss | 0 | |||||
| frameshift | 19 | 29 | 13 | 61 | ||
| splice donor/acceptor (+/-2bp) | 3 | 15 | 15 | 33 | ||
| Total | 36 | 87 | 350 | 72 | 6 | 551 |
Highest pathogenic variant AF is 0.00004275326
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006609.3 | 27 | MANE Select | |
| Ensembl | ENSP00000356234.3 | 27 | MANE Select | |
| RefSeq | NP_001300971.1 | 28 | Standard | |
| RefSeq | NP_001334520.1 | 26 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- Generic Transcription Pathway
- HDMs demethylate histones
- RNA Polymerase II Transcription
- Chromatin modifying enzymes
Biological Process
- negative regulation of transcription by RNA polymerase II
- chromatin remodeling
- regulation of transcription by RNA polymerase II
- single fertilization
- post-embryonic development
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
- transcription corepressor activity
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
- histone methyltransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367265
- Coding exons
- 27
- Length
- 82073
- Individuals with no LoFs
- 125620
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 128
- Defined
- 125748
- p
- 0.000509
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.78 | 701 | 847 | 0.828 | 0.0000454 | 10098 |
| Missense (PolyPhen) | 226 | 331.32 | 0.68212 | 3976 | ||
| Synonymous | 0.822 | 294 | 312 | 0.941 | 0.0000159 | 2954 |
| Loss of Function | 4.96 | 40 | 91.1 | 0.439 | 0.00000581 | 989 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0.00040 | 0.00040 | rare |
| East Asian | 0.0024 | 0.0024 | notable |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00044 | 0.00043 | rare |
| South Asian | 0.00027 | 0.00026 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:24952722, PubMed:27214403, PubMed:28262558). Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5 (PubMed:24952722). In contrast, may act as a tumor suppressor for melanoma. Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:Q80Y84, ECO:0000269|PubMed:12657635, ECO:0000269|PubMed:16645588, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17363312, ECO:0000269|PubMed:24952722, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:26741168, ECO:0000269|PubMed:27214403, ECO:0000269|PubMed:28262558}.;
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- LoFtool
- 0.176
- RVIS EVS
- -1.72
- RVIS percentile EVS
- 2.48
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.636
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |